
SINT Stock Forecast & Price Target
SINT Analyst Ratings
Bulls say
SINTX Technologies Inc. has shown a positive outlook based on a net present value (NPV) analysis, indicating significant upside potential from the current share price. The company’s ramp-up in biomedical commercialization, alongside a recent acquisition, is expected to further enhance its growth prospects. Additionally, the anticipated expansion of the global antimicrobial fertilizer and crop protection market, projected to reach $10 billion by 2030, may provide further opportunities for SINTX’s diverse applications in antipathogenic sectors.
Bears say
SINTX Technologies Inc. reported a substantial net loss of $10.3 million, resulting in an earnings per share (EPS) of $(3.46), which significantly missed prior estimates. This financial underperformance raises concerns regarding the company's balance sheet and liquidity, particularly in light of the various risks associated with product development, regulatory approvals, and commercialization efforts. Additionally, ongoing challenges related to competition and macroeconomic factors further compound the negative outlook for the company's financial stability and growth potential.
This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
SINT Analyst Forecast & Price Prediction
Start investing in SINT
Order type
Buy in
Order amount
Est. shares
0 shares